EXPEDITORS INTERNATIONAL OF WASHINGTON INC
For the period ended Mar 31, 2024. Filed May 9, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 9, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1A. Risk Factors
In addition to the other information set forth in this report, careful consideration should be given to the risk factors under Item 1A Risk Factors in our Annual Report on Form 10-K filed on February 23, 2024. There have been no material changes in Expeditors' risk factors from those disclosed under Item 1A Risk Factors in our annual report on Form 10-K filed on February 23, 2024.
ISSUER PURCHASES OF EQUITY SECURITIES
| Period | Total numberof sharespurchased | Average pricepaid per share | Total numberof sharespurchased aspart of publiclyannouncedplans | Maximumnumber ofshares that mayyet bepurchasedunder the plans |
|---|---|---|---|---|
| January 1-31, 2024 | - | - | - | 3,888 |
| February 1-29, 2024 | 992 | $118.11 | 992 | 13,122 |
| March 1-31, 2024 | 2,008 | 121.19 | 2,008 | 11,119 |
| Total | 3,000 | $120.17 | 3,000 | 11,119 |
In November 2001, Expeditors' Board of Directors authorized a Discretionary Stock Repurchase Plan for the purpose of repurchasing our common stock in the open market to reduce the issued and outstanding stock down to 200 million outstanding shares. Subsequently, the Board of Directors has from time to time increased the amount of our common stock that may be repurchased. On February 19, 2024, the Board of Directors last authorized repurchases from 140 million shares of common stock down to 130 million outstanding shares of common stock. The maximum number of shares available for repurchase under this plan will increase as the total number of outstanding shares increases. This authorization has no expiration date.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.